Connect Biopharma Holdings
CNTB
16 hedge funds and large institutions have $10.9M invested in Connect Biopharma Holdings in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.
8% more capital invested
Capital invested by funds: $10.1M → $10.9M (+$822K)
1.3% less ownership
Funds ownership: 21.13% → 19.83% (-1.3%)
24% less funds holding
Funds holding: 21 → 16 (-5)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$79.6K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$7.15K |
| 3 |
Renaissance Technologies
New York
|
+$5.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$519K |
| 2 |
Citigroup
New York
|
-$121K |
| 3 |
E
Ergoteles
New York
|
-$38.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
CNTB Hedge Fund Activity: Q1 2023 in Review
16 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2023, worth a combined $10.9M — up 8.1% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CNTB and 0 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was JP Morgan Chase, adding an estimated $79.6K. The largest seller was Sio Capital Management, exiting entirely with an estimated $519K sold.
- 16 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2023, down from 21 in Q4 2022.
- Funds reported $10.9M of Connect Biopharma Holdings stock for Q1 2023, up 8.1% quarter-over-quarter.
- 0 funds opened new Connect Biopharma Holdings positions in Q1 2023 and 5 closed out, a net change of -5 holders.
- The largest Connect Biopharma Holdings buyer in Q1 2023 was JP Morgan Chase, an estimated $79.6K added.
- The largest Connect Biopharma Holdings seller in Q1 2023 was Sio Capital Management, an estimated $519K sold.
Based on aggregated 13F filings for Q1 2023.